4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001405253-26-000005
See Remarks acquired 13,042 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farrow Jeffrey S See Remarks | 2026-03-15 | Option exercise | +13,042 | 49,746 | D | ||
| Derivatives | |||||||
| Farrow Jeffrey S See Remarks | 2026-03-15 | Option exercise · Restricted Stock Units | −8,020 | 16,040 | D | ||
| Farrow Jeffrey S See Remarks | 2026-03-15 | Option exercise · Restricted Stock Units | −5,022 | 15,067 | D | ||
Loading xslF345X05/wk-form4_1773779217.xml…